Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Adrenal disorders can cause lasting brain and behavior issues in children.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

New therapies are being developed that target integrin pathways to treat various diseases.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The dietary supplement helped increase hair growth in women with hair loss.